4//SEC Filing
Jayagopal Ashwath 4
Accession 0000905148-24-000742
CIK 0001228627other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:35 PM ET
Size
7.1 KB
Accession
0000905148-24-000742
Insider Transaction Report
Form 4
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
Transactions
- Award
Common Stock
2024-02-12+75,000→ 75,000 total - Award
Employee Stock Option (right to buy)
2024-02-12+225,000→ 225,000 totalExercise: $2.66Exp: 2034-02-11→ Common Stock (225,000 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of February 12, 2024, subject to the Reporting Person's continuing service.
- [F2]The option will vest with respect to 25% on February 12, 2025, with the remaining shares vesting quarterly in 12 equal installments thereafter, subject to the Reporting Person's continuing service.
Documents
Issuer
Ocuphire Pharma, Inc.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0002008983
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 6:35 PM ET
- Size
- 7.1 KB